Inhaled synthetic surfactant abolishes the early allergen-induced response in asthma

Babu K.S., Woodcock D.A., Smith S.E., Staniforth J.N., Holgate S.T., Conway J.H.

Source: Eur Respir J 2003; 21: 1046-1049
Journal Issue: June
Disease area: Airway diseases

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Babu K.S., Woodcock D.A., Smith S.E., Staniforth J.N., Holgate S.T., Conway J.H.. Inhaled synthetic surfactant abolishes the early allergen-induced response in asthma. Eur Respir J 2003; 21: 1046-1049

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Montelukast as add-on therapy to β-agonists and late airway response
Source: Eur Respir J 2007; 30: 56-61
Year: 2007



Effect of an inhaled alpha4-antagonist on the allergen-induced late asthmatic response in patients with mild asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 135s
Year: 2005

Bronchodilator effect of deep inhalation, airway inflammation, and allergen avoidance in asthmatic children
Source: Eur Respir J 2003; 22: Suppl. 45, 383s
Year: 2003

Effect of formoterol with or without budesonide in repeated low-dose allergen challenge
Source: Eur Respir J 2009; 33: 747-753
Year: 2009



The inhaled PDE4 inhibitor UK-500,001 does not significantly inhibit airway responses to allergen and histamine
Source: Annual Congress 2007 - New drugs for asthma
Year: 2007


Bronchial hyperresponsiveness to methacholine/AMP and the bronchodilator response in asthmatic children
Source: Eur Respir J 2011; 37: 800-805
Year: 2011



The effect of single dose montelukast and desloratadine, alone and in combination, on the allergen induced late airway response in atopic asthma
Source: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment
Year: 2008



Effects of salbutamol and enantiomers on allergen-induced asthmatic reactions and airway hyperreactivity
Source: Eur Respir J 2005; 25: 864-872
Year: 2005



Budesonide prevents but does not reverse sustained airway hyperresponsiveness in mice
Source: Eur Respir J 2008; 32: 970-978
Year: 2008



Reduced late asthmatic response by repeated low-dose allergen exposure
Source: Eur Respir J 2001; 17: 872-880
Year: 2001



Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma
Source: Eur Respir J 2002; 20: 1080-1087
Year: 2002



Inhaled corticosteroids and growth of airway function in asthmatic children
Source: Eur Respir J 2004; 23: 861-868
Year: 2004



Montelukast versus fluticasone: effects on lung function, airway responsiveness and inflammation in moderate asthma
Source: Eur Respir J 2002; 20: 853-858
Year: 2002



Esomeprazole 80 mg single-dose improves the bronchial response to MCh in non atopic GER-related asthma
Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population
Year: 2005


Bronchial effects of formaldehyde on inhaled allergenic challenge in patients with intermittent asthma
Source: Annual Congress 2005 - Cleaning and cooking: a risk for occupational and household asthma
Year: 2005


Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma
Source: Eur Respir J 2009; 33: 1277-1286
Year: 2009



IPL576,092 reduces allergen-induced late asthmatic responses, sputum eosinophilia and airway hyperresponsiveness in mild asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 104s
Year: 2003

Effect of IgE sensitization and allergen exposure on exhaled NO during inhaled corticosteroid (ICS) treatment in patients with asthma
Source: Annual Congress 2007 - Primary care respiratory problems
Year: 2007


Repeated inhaled airway allergen challenge model in asthma
Source: Annual Congress 2009 - Inflammation and airways
Year: 2009

Changes in objective markers following inhaled corticosteroids (ICS) in asthmatics with airway hyperresponsiveness (AHR) to mannitol
Source: International Congress 2019 – Airway physiology
Year: 2019